5 key milestones in senolytic drug development

Dasatinib and quercetin were the first successful senolytic drugs.

Clinical trials for Alzheimer's disease using senolytics began recently.

First human trial of D + Q showed improved physical function in IPF patients.

Second generation senolytics aim for greater selectivity and fewer side effects.